DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

58.54 -0.42 (-0.71%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $58.54 -0.71%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.89
Previous Close $58.96
Daily Range $58.49 - $59.06
52-Week Range $52.49 - $63.62
Market Cap $166.9B
P/E Ratio 14.49
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 13,059,817
Average Daily Volume 9,956,905
Current FY EPS $3.41




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog

Dow Jones (DJIA) Today: Merck (MRK) Lower

Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers

Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN

A Quick Review Of The Asthma Market

Abner Herrman's Top Three Holdings

Long-term investor: Irving Kahn, who shorted 1929 Crash, dies at 109

Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Intel (INTC) Lags

See More MRK News...

MRK's Top Competitors

MRK $58.54 (-0.71%)
Current stock: MRK
NVS $102.40 (-0.58%)
Current stock: NVS
JNJ $102.51 (-0.28%)
Current stock: JNJ
RHHBY $34.13 (0.80%)
Current stock: RHHBY